| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/12/2014 | US20140161753 Self-Assembling Peptide and Peptide Gel with High Strength |
| 06/12/2014 | US20140161725 Molecular Imaging of Cancer Cells In Vivo |
| 06/11/2014 | EP2740484A1 Compounds useful in the treatment and/or care of the skin, hair and/or muccous membranes and their cosmetic or pharmaceutical compositions |
| 06/11/2014 | EP2739741A1 Organelle targeting nanocarriers |
| 06/11/2014 | CN103848900A Method for separating WF11899A from fermentation liquor and purifying |
| 06/11/2014 | CN103848899A Antigenic mimic epitope Ph15 of bisphenol A and application thereof |
| 06/11/2014 | CN103848898A Antigenic mimic epitope Ph3 of bisphenol A and application thereof |
| 06/11/2014 | CN103848897A Antigenic mimic epitope Ph1 of bisphenol A and application thereof |
| 06/11/2014 | CN103848896A Antigenic mimic epitope Ph5 of bisphenol A and application thereof |
| 06/11/2014 | CN103848895A Mimic epitope of linear dodecapeptide antigen of aflatoxin B1 and application thereof |
| 06/11/2014 | CN103848894A Novel compound containing daptomycin structure as well as preparation method and application thereof |
| 06/11/2014 | CN103848893A Purifying method of linaclotide |
| 06/11/2014 | CN103848892A Antigen polypeptide capable of recognizing UROD autoantibody |
| 06/11/2014 | CN103848891A Antigen polypeptide capable of recognizing CCND1 autoantibody |
| 06/11/2014 | CN103848890A Antigen polypeptide identified by MUC1 antoantibody |
| 06/11/2014 | CN103848889A Antigen polypeptide identified by IGF2BP1 antoantibody |
| 06/11/2014 | CN103848888A Antigenic peptides and antibodies thereof of human complement C1q/TNF alpha (tumor necrosis factor alpha) related protein-2 (hCTRP2) |
| 06/11/2014 | CN103848887A Synthetic peptide as well as preparation method and application thereof |
| 06/11/2014 | CN103073621B Minced tuna protein antioxidative peptide and preparation method and use thereof |
| 06/11/2014 | CN102875650B Preparation method of barusiban |
| 06/11/2014 | CN102786582B Tem8 peptides and vaccines comprising the same |
| 06/11/2014 | CN102702310B Marine peptides compounds and application of marine peptides compounds to preparation of angiogenesis medicines |
| 06/11/2014 | CN102558307B Octapeptin as well as preparation and application thereof |
| 06/10/2014 | US8748575 Therapeutic peptides |
| 06/10/2014 | US8748573 Formulations comprising linaclotide |
| 06/10/2014 | US8748572 RNase a peptides, fragments and uses thereof |
| 06/10/2014 | US8748566 Pharmacologically active antiviral peptides and methods of use |
| 06/10/2014 | US8748565 Pharmacologically active antiviral peptides and methods of their use |
| 06/10/2014 | US8748564 Oxytocin receptor agonists |
| 06/10/2014 | US8748398 Stroke-targeting peptide and use thereof |
| 06/10/2014 | US8748395 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 06/10/2014 | US8748394 Apo A-I mimetic peptides and methods of treatment |
| 06/10/2014 | US8748390 Immunogenic epitopes of NGEP antigen |
| 06/10/2014 | US8748389 Treating cancer |
| 06/10/2014 | US8748388 Antitumoral compounds |
| 06/10/2014 | US8748373 Hepatitis B virus compositions and methods of use |
| 06/10/2014 | US8748371 Nuclear targeting sequences |
| 06/10/2014 | US8748352 Peptide and protein biomarkers for type 1 diabetes mellitus |
| 06/10/2014 | US8748170 Polypeptides derived from cyclin B1 and uses thereof |
| 06/10/2014 | US8748105 Method for selecting a candidate drug compound |
| 06/10/2014 | US8747808 Radiolabeled annexins |
| 06/10/2014 | CA2441287C Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 06/05/2014 | WO2014085637A1 New lantibiotic derivatives and a process for their preparation |
| 06/05/2014 | WO2014085623A1 Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues |
| 06/05/2014 | WO2014085621A1 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof |
| 06/05/2014 | WO2014085297A1 Multifunctional bacteriophage for delivery of therapeutic agents and imaging reagents |
| 06/05/2014 | WO2014084378A1 Anticancer drug comprising cyclic rgd sequence-containing peptide |
| 06/05/2014 | US20140155576 F11 receptor (f11r) antagonists as therapeutic agents |
| 06/05/2014 | US20140155575 Process of Preparing Guanylate Cyclase C Agonists |
| 06/05/2014 | US20140155323 Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides |
| 06/05/2014 | US20140155319 Antimicrobial compositions and methods of use thereof |
| 06/05/2014 | US20140155318 Peptides and compositions for prevention of cell adhesion and methods of using same |
| 06/05/2014 | US20140155315 Synthetic linear apelin mimetics for the treatment of heart failure |
| 06/05/2014 | US20140154291 Inhibition of trem receptor signaling with peptide variants |
| 06/05/2014 | US20140154208 Novel [N-Me-4-hydroxyleucine]-9-Cyclosporin Analogues for Treatment and Prevention of Hepatitis C Infection |
| 06/05/2014 | US20140154192 Glutathione analogs and uses thereof |
| 06/05/2014 | US20140154181 Rgd-containing peptidomimetics and uses thereof |
| 06/04/2014 | EP2738256A2 Use of the peptide gk-1 expressed in the filamentous phage m13 for preparing pharmaceutical products that increase the effectiveness of the immune response induced by vaccine antigens or pathogens |
| 06/04/2014 | CN103842373A Template -fixed peptidomimetics as inhibitors of FPR1 |
| 06/04/2014 | CN103842372A Cyclosporin derivatives |
| 06/04/2014 | CN103842371A Silk-based bioactive oligopeptide compositions and manufacturing process therefor |
| 06/04/2014 | CN103833858A Pair of polypeptides, and encoding gene and application thereof |
| 06/04/2014 | CN103833832A Melanocortin receptor-specific peptides |
| 06/04/2014 | CN103833831A Method for preparing carbetocin |
| 06/04/2014 | CN103833830A Conservative neutralizing epitope polypeptide of Coxsackievirus A16 and application thereof |
| 06/04/2014 | CN103833829A Radioactive <18>F-labeled imaging drug <18>F-AL-NOTA-IF7 targeting Anxa1 in tumor blood vessels and preparation method thereof |
| 06/04/2014 | CN103833828A Extraction method of insulin glargine precursor protein |
| 06/04/2014 | CN103214556B Anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide from MAT1 (Metastasis Associated Gene1) and application thereof |
| 06/04/2014 | CN103048395B Deletion peptide of 20 peptide phase for solid-phase synthesis of thymosin alpha 1, non-peptide impurity and detection method |
| 06/04/2014 | CN102807605B Nalpha-(1,3-dioxo-4,4,5,5-tetramethylimidazoline-2-phenyl-4'-oxyacetyl)-Nomega-fatty acyl-Lys-Arg-Gly-Asp-Phe and preparation method and application thereof |
| 06/04/2014 | CN102807604B N alpha-(1,3-dioxy-4,4,5,5-tetramethyl imidazoline-2-phenyl-4'-oxo acetyl)-N omega-fatty acyl-Lys-Arg-Gly-Asp-Val and preparation method and application thereof |
| 06/04/2014 | CN102731621B Peptide segment of specific targeting human embryonic stem cell and application thereof |
| 06/04/2014 | CN102731620B Peptide segment of specific targeting human embryonic stem cell |
| 06/04/2014 | CN102731618B Peptide of specific target human embryonic stem cell, and its application |
| 06/04/2014 | CN102702329B Synthesis of template-fixed Beta-hairpin loop mimics |
| 06/04/2014 | CN102690329B Purification production method of goserelin polypeptide |
| 06/04/2014 | CN102516357B Polypeptide combined with A-beta amyloid and application thereof |
| 06/04/2014 | CN102443050B Method for purifying cyclic lipopeptide compound or salt thereof |
| 06/03/2014 | US8741852 Peptides having antimicrobial activity |
| 06/03/2014 | US8741851 Peptides having antimicrobial activity |
| 06/03/2014 | US8741850 Compounds modulators of VEGF activity and uses thereof |
| 06/03/2014 | US8741838 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 06/03/2014 | US8741576 Heteroclitic analogs and related methods |
| 06/03/2014 | US8741303 Immunogenic LHRH compositions and methods relating thereto |
| 06/03/2014 | US8741272 Use of novel amino acid derivatives as agents for treating human perspiration, and compositions containing them |
| 06/03/2014 | CA2395892C Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 05/30/2014 | WO2014082042A2 Peptides that stimulate subcutaneous adipogenesis |
| 05/30/2014 | WO2014081864A1 Improved peptide pharmaceuticals |
| 05/30/2014 | WO2014081728A1 Inhibitors of the t cell-specific alternative p38 activation pathway and methods of use |
| 05/30/2014 | WO2014080350A1 Immunomodulatory peptides and methods of use thereof |
| 05/30/2014 | WO2014079979A1 New nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio)molecules; precursors and conjugates thereof |
| 05/30/2014 | WO2014078896A1 Complex-formation-modulating agents and uses therefor |
| 05/30/2014 | WO2014078890A1 Chlamydia trachomatis diagnostic peptide and method |
| 05/30/2014 | WO2014078889A1 Improved inhibitors of grb7 |
| 05/29/2014 | US20140148394 Compositions and methods for modulating gamma-c-cytokine activity |
| 05/29/2014 | US20140148393 Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation |
| 05/29/2014 | US20140148378 Antibacterial peptides |
| 05/29/2014 | US20140147455 Antigen surrogates in autoimmune disease |
| 05/29/2014 | US20140147416 Engineering the production of a conformational variant of occidiofungin that has enhanced inhibitory activity against fungal species |
| 05/29/2014 | US20140147380 Guanylylcyclase c ligands |